Histogen

Histogen Corporate
Factsheet
Home About Histogen > News and Events

Latest News
Renowned Dermatologist Dr. Neil Sadick Joins Histogen Scientific Advisory Board

Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation

Human Extracellular Matrix Significantly Improves Device Biocompatibility

Hypoxia Induces Stem Cell Gene Expression, Protein Production and Cell Surface Markers

More >>  

Upcoming Events

ASAIO Annual Conference
May 27-29, 2010
Baltimore, MD
Histogen to present "Coating Polymers with a Human Extracellular Matrix (hECM) Significantly Improves Implant Biocompatibility"

International Society for Stem Cell Research (ISSCR) Annual Meeting
June 16-19, 2010
San Francisco, CA
Histogen to present "Human Embryonic-Like ECM (hECM) Stimulates Proliferation and Differentiation in Stem Cells While Killing Cancer Cells"

Histogen's proprietary tissue-engineering process is utilized for manufacturing all of Histogen's products. Newborn fibroblasts are placed into a bioreactor and conditioned with a liquid media.
  • ReGenicaTM 's components have recently been shown to be critical for new hair follicle formation
  • The field of stem cell research is rapidly expanding
  • Histogen scientists have developed regenerative medical technologies without the use of stem cells or animal serum
  • Histogen has a foundation of proven products
© Histogen Inc., CA 92101